Join Us

We are 225,049 members in 83 forums discussing 163,855 topics.

Help with Abbreviations

Topic: New BCO Content on Recently Approved Immunotherapy Jemperli

Forum: Immunotherapy - Before, During, and After —

Discuss your experiences with the benefits, risks, and side effects of immunotherapy treatment for breast cancer.

Posted on: Sep 1, 2021 12:58PM

Moderators wrote:

Jemperli (chemical name: dostarlimab-gxly) is approved by the U.S. Food and Drug Administration (FDA) to treat mismatch repair deficient (dMMR) advanced-stage breast cancer that has grown during or after treatment if no other treatment options are available.

Jemperli also is approved to treat dMMR advanced-stage endometrial cancer that has grown after treatment with platinum chemotherapy.

Learn more about:

Read more.

To send a Private Message to the Mods: community.breastcancer.org/mem...
Log in to post a reply